Literature DB >> 11581144

Developing a vasopressor combination in a pig model of adult asphyxial cardiac arrest.

V D Mayr1, V Wenzel, W G Voelckel, A C Krismer, T Mueller, K G Lurie, K H Lindner.   

Abstract

BACKGROUND: The purpose of this study was to investigate the effects of vasopressin versus epinephrine, and both drugs combined, in a porcine model of simulated adult asphyxial cardiac arrest. METHODS AND
RESULTS: At approximately 7 minutes after the endotracheal tube had been clamped, cardiac arrest was present in 24 pigs and remained untreated for another 8 minutes. After 4 minutes of basic life support cardiopulmonary resuscitation, pigs were randomly assigned to receive, every 5 minutes, either epinephrine (45, 200, or 200 microgram/kg; n=6); vasopressin (0.4, 0.8, or 0.8 U/kg; n=6); or epinephrine combined with vasopressin (high-dose epinephrine/vasopressin combination, microgram/kg and U/kg: 45/0.4, 200/0.8, or 200/0.8; n=6; optimal-dose epinephrine/vasopressin combination, 45/0.4, 45/0.8, or 45/0.8; n=6). Mean+/-SEM coronary perfusion pressure was significantly (P<0.05) higher 90 seconds after high- or optimal-dose epinephrine/vasopressin combinations versus vasopressin alone and versus epinephrine alone (37+/-10 versus 25+/-7 versus 19+/-8 versus 6+/-3 mm Hg; 42+/-6 versus 40+/-5 versus 21+/-5 versus 14+/-6 mm Hg; and 39+/-6 versus 37+/-4 versus 9+/-3 versus 12+/-4 mm Hg, respectively). Six of 6 high-dose, 6 of 6 optimal-dose vasopressin/epinephrine combination, 0 of 6 vasopressin, and 1 of 6 epinephrine pigs had return of spontaneous circulation (P<0.05).
CONCLUSIONS: Epinephrine combined with vasopressin, but not epinephrine or vasopressin alone, maintained elevated coronary perfusion pressure during cardiopulmonary resuscitation and resulted in significantly higher survival rates in this adult porcine asphyxial model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581144     DOI: 10.1161/hc3901.095896

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

Review 1.  [Resuscitation after prehospital cardiovascular arrest].

Authors:  T Klingenheben; A M Zeiher; S Fichtlscherer
Journal:  Internist (Berl)       Date:  2005-03       Impact factor: 0.743

2.  Experimental cardiac arrest treatment with adrenaline, vasopressin, or placebo.

Authors:  Manoel Ângelo Gomes Palácio; Edison Ferreira de Paiva; Luciano Cesar Pontes de Azevedo; Ari Timerman
Journal:  Arq Bras Cardiol       Date:  2013-11-01       Impact factor: 2.000

3.  Employing vasopressin as an adjunct vasopressor in uncontrolled traumatic hemorrhagic shock. Three cases and a brief analysis of the literature.

Authors:  A C Krismer; V Wenzel; W G Voelckel; P Innerhofer; K H Stadlbauer; T Haas; M Pavlic; H J Sparr; K H Lindner; A Koenigsrainer
Journal:  Anaesthesist       Date:  2005-03       Impact factor: 1.041

4.  Lipid emulsion combined with epinephrine and vasopressin does not improve survival in a swine model of bupivacaine-induced cardiac arrest.

Authors:  Shawn D Hicks; David D Salcido; Eric S Logue; Brian P Suffoletto; Philip E Empey; Samuel M Poloyac; Donald R Miller; Clifton W Callaway; James J Menegazzi
Journal:  Anesthesiology       Date:  2009-07       Impact factor: 7.892

Review 5.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

Review 6.  Arginine vasopressin receptor signaling and functional outcomes in heart failure.

Authors:  Melissa A Wasilewski; Valerie D Myers; Fabio A Recchia; Arthur M Feldman; Douglas G Tilley
Journal:  Cell Signal       Date:  2015-07-30       Impact factor: 4.315

7.  β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling.

Authors:  Douglas G Tilley; Weizhong Zhu; Valerie D Myers; Larry A Barr; Erhe Gao; Xue Li; Jianliang Song; Rhonda L Carter; Catherine A Makarewich; Daohai Yu; Constantine D Troupes; Laurel A Grisanti; Ryan C Coleman; Walter J Koch; Steven R Houser; Joseph Y Cheung; Arthur M Feldman
Journal:  Circulation       Date:  2014-09-09       Impact factor: 29.690

Review 8.  Brain resuscitation in the drowning victim.

Authors:  Alexis A Topjian; Robert A Berg; Joost J L M Bierens; Christine M Branche; Robert S Clark; Hans Friberg; Cornelia W E Hoedemaekers; Michael Holzer; Laurence M Katz; Johannes T A Knape; Patrick M Kochanek; Vinay Nadkarni; Johannes G van der Hoeven; David S Warner
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

9.  Effect of vasopressin on hippocampal injury in a rodent model of asphyxial cardiopulmonary arrest.

Authors:  Nan Zhang; Xiu-Xian Zang; Ning Dong; Fang Liu; Shao-Kun Wang; H E Yan; DA-Hai Xu; Xiao-Liang Liu; L I Pang
Journal:  Exp Ther Med       Date:  2016-01-28       Impact factor: 2.447

10.  The physiologic response to rescue therapy with vasopressin versus epinephrine during experimental pediatric cardiac arrest.

Authors:  Julia C Slovis; Ryan W Morgan; William P Landis; Anna L Roberts; Alexandra M Marquez; Constantine D Mavroudis; Yuxi Lin; Tiffany Ko; Vinay M Nadkarni; Robert A Berg; Robert M Sutton; Todd J Kilbaugh
Journal:  Resusc Plus       Date:  2020-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.